How important is gametocyte clearance after malaria therapy?

BMC Medicine

Volumn 14, Issue 1, 2016, Pages

  Karunajeewa, Harin A ^a,b   Mueller, Ivo ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Melbourne Health   (Australia)

^c INSTITUT PASTEUR   (France)

Author keywords

Antimalarial; Artemisinin combination therapy; Gametocyte clearance; Gametocytes; Malaria; P. falciparum

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE PLUS MEFLOQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

COMBINATION CHEMOTHERAPY; DISEASE TRANSMISSION; GAMETOCYTE; GAMETOCYTE CLEARANCE; HUMAN; LIFE CYCLE STAGE; MALARIA; MALARIA CONTROL; MICROSCOPY; NONHUMAN; NOTE; PARASITE CLEARANCE; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; ANIMAL; DRUG EFFECTS; MALARIA, FALCIPARUM; MOSQUITO; PARASITOLOGY; TRANSMISSION;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CULICIDAE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84975230306     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0641-3     Document Type: Note

References (13)

1. World Health Organization. World Malaria Report 2015. Geneva: WHO; 2015.
2. MalERA Consultative Group on Drugs. A research agenda for malaria eradication: drugs. PLoS Med. 2011;8(1):e1000402.
3. Young JA, Fivelman QL, Blair PL, de la Vega P, Le Roch KG, Zhou Y, Carucci DJ, Baker DA, Winzeler EA. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification. Mol Biochem Parasitol. 2005;143(1):67-79.
4. White NJ, Ashley EA, Recht J, Delves MJ, Ruecker A, Smithuis FM, Eziefula AC, Bousema T, Drakeley C, Chotivanich K, et al. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J. 2014;13:483.
5. Graves PM, Gelband H, Garner P. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Cochrane Database Syst Rev. 2014;6:CD008152.
6. Delves M, Plouffe D, Scheurer C, Meister S, Wittlin S, Winzeler EA, Sinden RE, Leroy D. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med. 2012;9(2):e1001169.
7. World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: WHO; 2015.
8. WWARN Gametocyte Study Group. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016;14:79.
9. White NJ. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis. 2013;13(2):175-81.
10. Beavogui AH, Djimde AA, Gregson A, Toure AM, Dao A, Coulibaly B, Ouologuem D, Fofana B, Sacko A, Tekete M. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. Int J Parasitol. 2010;40(10):1213-20.
11. Kone A, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Dara A, Niangaly H, Ouologuem D, Fofana B, Sacko A, Tekete M. Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int J Parasitol. 2010;40(10):1221-8.
12. Goncalves BP, Tiono AB, Ouedraogo A, Guelbeogo WM, Bradley J, Nebie I, Siaka D, Lanke K, Eziefula AC, Diarra A, et al. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial. BMC Med. 2016;14:40.
13. Johnston GL, Gething PW, Hay SI, Smith DL, Fidock DA. Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination. PLoS Comput Biol. 2014;10(1):e1003434.